H.C. Wainwright analyst Vernon Bernardino downgraded Neovasc (NVCN) to Neutral from Buy with a price target of $27.75, up from $20, after Shockwave Medical (SWAV) agreed to acquire all of the issued and outstanding common shares of the company for $27.25 per share.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on NVCN: